CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Phoenix Life Sciences International Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Phoenix Life Sciences International Limited
3000 Lawrence St
Phone: (720) 699-7222p:720 699-7222 DENVER, CO  80205-3422  United States Fax: (775) 525-2898f:775 525-2898
The Board of Directors of Phoenix Life Sciences International Ltd has determined that the Form 10-K for the Financial period ending February 28, 2019 can no longer be relied upon. Under the terms of the Settlement and Release agreement, a Form 10-K/A must be filed to correct information that is now inaccurate. This relates to current liabilities, statements regarding the share cancellation and other assets.
This company is no longer actively traded on any major stock exchange.
Business Summary
Phoenix Life Sciences International Limited is a healthcare solutions company. The Company provides a range of healthcare services to help governments implement diabetes solutions and national healthcare programs. It is primarily engaged in the provision of diabetes management as part of its healthcare services program and approved Phoenix Metabolic rollout. It operates an integrated group of companies for the fulfillment of government-sponsored healthcare service programs, plant-based pharmaceutical production and ongoing research programs. Its healthcare service programs are designed to provide solutions to manage diabetes and other non-communicable diseases (NCD). It partners and produces plant-based pharmaceuticals to treat diabetes, pain, cancer, autoimmune diseases and anxiety and other conditions. Its products include Phoenix Metabolic, Phoenix Auto, Phoenix Calm, Phoenix Daytime, Phoenix Mood, Phoenix Neuro, Phoenix Onco, Phoenix Pain, Phoenix Relax and Phoenix Sleep.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/20192/28/2019YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Lewis A.Humer 61 10/3/2018 4/25/2014
Chief Executive Officer, Managing Director JanelleMarsden 45 7/8/2019 10/3/2018
Chief Financial Officer, Director GeoffBoynton 61 10/3/2018 10/1/2018
Director StephenCornford 59 10/3/2018 10/3/2018

Business Names
Business Name
MJMD
Phoenix Life Sciences International Limited
PLSI

General Information
Outstanding Shares: 10,084,582 (As of 2/28/2019)
Shareholders: 269
Stock Exchange: OTC
Federal Tax Id: 460525378
Fax Number: (775) 525-2898


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 17, 2023